What is the current Bioxytran market capitalization?
The current market capitalization of Bioxytran is 10.35 M USD.
Bioxytran Market capitalization 2024
Bioxytran Market capitalization
10.35 M USD
Ticker
BIXT
ISIN
US09075D1028
In 2024, Bioxytran's market cap stood at 10.35 M USD, a -24.61% increase from the 13.73 M USD market cap in the previous year.
The Bioxytran Market capitalization history
| YEAR | Market Capitalization (undefined USD) |
|---|---|
| 2021 | 9.79 |
| 2020 | 19.88 |
| 2019 | 59.01 |
| 2018 | 75.35 |
| 2017 | 0.73 |
| 2016 | 1.27 |
| 2015 | 2.01 |
| 2014 | 4.97 |
| 2013 | 9.4 |
| 2012 | 7.37 |
| 2011 | - |
| 2010 | - |
| 2009 | - |
| 2008 | - |
Bioxytran Aktienanalyse
What does Bioxytran do?
Bioxytran Inc. is a US-based company specialized in the development of medical therapies based on the use of oxygen transport molecules. The company's patented platform technology focuses on the development of new innovative therapies for treating central nervous system disorders, cardiovascular diseases, and cancer treatment. The company was founded in 2014 by a group of scientists and entrepreneurs aiming to create a transformative medical product that improves oxygen transport in the body and enables the treatment of severe diseases. Bioxytran's platform is based on the use of perfluorocarbon compounds (PFCs) that have a strong affinity for oxygen and can bind and transport it in the blood. The company's business model is centered on the development and commercialization of new therapies to treat diseases such as stroke, heart attack, cancer, and even COVID-19. By improving oxygen transport in the body, Bioxytran aims to enhance the effectiveness of medical treatments and create new therapeutic possibilities. The company's focus areas include stroke treatment, where they have developed a technology that allows direct oxygen transport to the affected brain tissue, minimizing neural damage and enabling faster recovery. They have also developed a new type of heart attack treatment that aims to improve blood flow and eliminate oxygen deficiency in the heart, as well as another therapy option for patients suffering from acute heart attacks. In the field of cancer treatment, Bioxytran has a promising therapy in the pipeline based on PFCs that can selectively target cancer cells, potentially making chemotherapy more effective and patient-friendly. Overall, Bioxytran's goal is to develop medical therapies that have the potential to revolutionize the treatment of severe diseases. They offer a range of products and approaches that have the potential to improve the lives of many patients. In summary, Bioxytran Inc. is an emerging company in the field of medical therapies, driven by innovation and technological expertise. Their focus on developing high-potential products that improve oxygen transport in the body facilitates the treatment of severe diseases. With their various divisions and products, Bioxytran is able to address a broad spectrum of medical needs. Bioxytran ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Bioxytran's Market Capitalization
Bioxytran's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Bioxytran's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Bioxytran's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Bioxytran’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Bioxytran stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Bioxytran.
How has the market capitalization of Bioxytran developed in recent years?
The market capitalization of Bioxytran has increased/decreased by -24.61% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Bioxytran?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Bioxytran?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Bioxytran have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Bioxytran pay?
Over the past 12 months, Bioxytran paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bioxytran is expected to pay a dividend of 0 USD.
What is the dividend yield of Bioxytran?
The current dividend yield of Bioxytran is .
When does Bioxytran pay dividends?
Bioxytran pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Bioxytran?
Bioxytran paid dividends every year for the past 0 years.
What is the dividend of Bioxytran?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Bioxytran located?
Bioxytran is assigned to the 'Health' sector.
Wann musste ich die Aktien von Bioxytran kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Bioxytran from 11/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/17/2024.
When did Bioxytran pay the last dividend?
The last dividend was paid out on 11/17/2024.
What was the dividend of Bioxytran in the year 2023?
In the year 2023, Bioxytran distributed 0 USD as dividends.
In which currency does Bioxytran pay out the dividend?
The dividends of Bioxytran are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Bioxytran
Our stock analysis for Bioxytran Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bioxytran Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
